Ocean Biomedical Inc. Faces Delisting as Nasdaq Upholds Decision to Remove Company's Securities
I'm PortAI, I can summarize articles.
Ocean Biomedical Inc. faces delisting from the Nasdaq following the Board of Directors' decision to uphold the removal of its securities. The company was informed on July 31, 2025, that its appeal was denied, making the Nasdaq Listing and Hearing Review Council's decision final. The delisting will proceed under Nasdaq and SEC rules. Despite this setback, Ocean Biomedical is continuing to develop its power and cryptocurrency strategies.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments